GRETCHEN FOLEY: Open Payments
NPI 1437553187 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 20 payments from 7 companies in 2025. Trend: 2023 $481 · 2024 $1,029 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $220 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Boston Scientific Corporation | 1 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Amgen Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Wegovy, LEQVIO, CAMZYOS, WATCHMAN FLX, FARXIGA, REPATHA, Ozempic, Kerendia.
Industry payments across ID — which companies pay providers there.
